Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as Patches for 96 Hours and for 72 Hours

NCT03770234 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain
Pharmacokinetics

Interventions

DRUG: Transtec 35 µg/hour transdermal patch

Sponsor

Grünenthal GmbH